These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 34063805)

  • 1. Analysis and Interpretation of the Impact of Missense Variants in Cancer.
    Petrosino M; Novak L; Pasquo A; Chiaraluce R; Turina P; Capriotti E; Consalvi V
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRIMEtoYHU: a new web tool to develop yeast-based functional assays for characterizing cancer-associated missense variants.
    Mercatanti A; Lodovichi S; Cervelli T; Galli A
    FEMS Yeast Res; 2017 Dec; 17(8):. PubMed ID: 29069390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Approaches to Prioritize Cancer Driver Missense Mutations.
    Zhao F; Zheng L; Goncearenco A; Panchenko AR; Li M
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30037003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Identification of Deleterious
    Tam B; Sinha S; Qin Z; Wang SM
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics.
    Ernst C; Hahnen E; Engel C; Nothnagel M; Weber J; Schmutzler RK; Hauke J
    BMC Med Genomics; 2018 Mar; 11(1):35. PubMed ID: 29580235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate prediction of functional, structural, and stability changes in PITX2 mutations using in silico bioinformatics algorithms.
    Seifi M; Walter MA
    PLoS One; 2018; 13(4):e0195971. PubMed ID: 29664915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-silico Analysis of
    Accetturo M; Bartolomeo N; Stella A
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979111
    [No Abstract]   [Full Text] [Related]  

  • 8. Comprehensive characterization of amino acid positions in protein structures reveals molecular effect of missense variants.
    Iqbal S; Pérez-Palma E; Jespersen JB; May P; Hoksza D; Heyne HO; Ahmed SS; Rifat ZT; Rahman MS; Lage K; Palotie A; Cottrell JR; Wagner FF; Daly MJ; Campbell AJ; Lal D
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28201-28211. PubMed ID: 33106425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of pathogenic missense mutations using protein stability predictors.
    Gerasimavicius L; Liu X; Marsh JA
    Sci Rep; 2020 Sep; 10(1):15387. PubMed ID: 32958805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of computational methods for predicting the effects of missense mutations in human cancers.
    Gnad F; Baucom A; Mukhyala K; Manning G; Zhang Z
    BMC Genomics; 2013; 14 Suppl 3(Suppl 3):S7. PubMed ID: 23819521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DARVIC: Dihedral angle-reliant variant impact classifier for functional prediction of missense VUS.
    Lagniton PNP; Tam B; Wang SM
    Comput Methods Programs Biomed; 2023 Aug; 238():107596. PubMed ID: 37201251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curated multiple sequence alignment for the Adenomatous Polyposis Coli (APC) gene and accuracy of in silico pathogenicity predictions.
    Karabachev AD; Martini DJ; Hermel DJ; Solcz D; Richardson ME; Pesaran T; Sarkar IN; Greenblatt MS
    PLoS One; 2020; 15(8):e0233673. PubMed ID: 32750050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic missense protein variants affect different functional pathways and proteomic features than healthy population variants.
    Laddach A; Ng JCF; Fraternali F
    PLoS Biol; 2021 Apr; 19(4):e3001207. PubMed ID: 33909605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic prediction of familial hypercholesterolemia caused by low-density lipoprotein receptor missense mutations.
    Guo J; Gao Y; Li X; He Y; Zheng X; Bi J; Hou L; Sa Y; Zhang M; Yin H; Jiang L
    Atherosclerosis; 2019 Feb; 281():1-8. PubMed ID: 30583242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1- and BRCA2-specific in silico tools for variant interpretation in the CAGI 5 ENIGMA challenge.
    Padilla N; Moles-Fernández A; Riera C; Montalban G; Özkan S; Ootes L; Bonache S; Díez O; Gutiérrez-Enríquez S; de la Cruz X
    Hum Mutat; 2019 Sep; 40(9):1593-1611. PubMed ID: 31112341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIGMA leverages protein structural information to predict the pathogenicity of missense variants.
    Zhao H; Du H; Zhao S; Chen Z; Li Y; Xu K; Liu B; Cheng X; Wen W; Li G; Chen G; Zhao Z; Qiu G; ; Liu P; Zhang TJ; Wu Z; Wu N
    Cell Rep Methods; 2024 Jan; 4(1):100687. PubMed ID: 38211594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. News from the protein mutability landscape.
    Hecht M; Bromberg Y; Rost B
    J Mol Biol; 2013 Nov; 425(21):3937-48. PubMed ID: 23896297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated in silico approach to analyze the involvement of single amino acid polymorphisms in FANCD1/BRCA2-PALB2 and FANCD1/BRCA2-RAD51 complex.
    Doss CG; Nagasundaram N
    Cell Biochem Biophys; 2014 Nov; 70(2):939-56. PubMed ID: 24817641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PON-P: integrated predictor for pathogenicity of missense variants.
    Olatubosun A; Väliaho J; Härkönen J; Thusberg J; Vihinen M
    Hum Mutat; 2012 Aug; 33(8):1166-74. PubMed ID: 22505138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico Analysis of the Missense Variants of Uncertain Significance of
    Caballero-Avendaño A; Gutiérrez-Angulo M; Ayala-Madrigal ML; Moreno-Ortiz JM; González-Mercado A; Peregrina-Sandoval J
    Genes (Basel); 2024 Jul; 15(8):. PubMed ID: 39202333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.